Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 421,541 | 17,130 | 27,900 | 9,266 | 14,141 |
| Marketable Securities | 239,632 | 6,890 | 59,230 | 63,003 | 64,050 |
| Receivables | N/A | 3,000 | 0 | 0 | 0 |
| Other current assets | 1,980 | 3,730 | 4,610 | 779 | 1,250 |
| TOTAL | $663,153 | $30,750 | $91,740 | $73,048 | $79,441 |
| Non-Current Assets | |||||
| PPE Net | 37,673 | 38,040 | 23,010 | 9,996 | 8,590 |
| Investments And Advances | 0 | 113,200 | 56,290 | 91,386 | 21,475 |
| Other Non-Current Assets | 4,154 | 540 | 780 | 596 | 825 |
| TOTAL | $41,827 | $151,780 | $80,080 | $101,978 | $30,890 |
| Total Assets | $704,980 | $182,550 | $171,850 | $175,026 | $110,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 400 | 360 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 1,062 | 870 | 1,310 | 475 | 1,029 |
| Accrued Expenses | 5,903 | 4,560 | 5,800 | 4,479 | 4,191 |
| Other current liabilities | N/A | 2,270 | 2,230 | 1,604 | 0 |
| TOTAL | $11,512 | $8,080 | $9,350 | $6,558 | $5,220 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,324 | 9,720 | 0 | 0 | 0 |
| Deferred Revenues | 1,455 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 150,000 | 0 | 0 | 0 | 0 |
| TOTAL | $159,324 | $9,720 | $N/A | $N/A | $N/A |
| Total Liabilities | $170,836 | $17,800 | $9,350 | $6,558 | $5,220 |
| Shareholders' Equity | |||||
| Common Shares | 872 | 190 | 180 | 183 | 157 |
| Retained earnings | -78,570 | -79,210 | -68,880 | -59,382 | -35,507 |
| Other shareholders' equity | 588 | -2,050 | 160 | 574 | 133 |
| TOTAL | $534,144 | $164,740 | $162,490 | $168,468 | $105,111 |
| Total Liabilities And Equity | $704,980 | $182,540 | $171,840 | $175,026 | $110,331 |